metformin has been researched along with Fournier Disease in 2 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "On examination, he was afebrile and hemodynamically stable." | 1.46 | Fournier's gangrene in a man on empagliflozin for treatment of Type 2 diabetes. ( Colman, PG; Costello, AJ; Kumar, S, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, S | 1 |
| Costello, AJ | 1 |
| Colman, PG | 1 |
| Muharremi, S | 1 |
2 other studies available for metformin and Fournier Disease
| Article | Year |
|---|---|
Fournier's gangrene in a man on empagliflozin for treatment of Type 2 diabetes.
Topics: Adult; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Drug Substitution; Drug Therapy, Combination | 2017 |
FOURNIER'S GANGRENE, A RARE COMPLICATION OF DIABETES MELLITUS (CASE REPORT).
Topics: Diabetes Mellitus, Type 2; Fatal Outcome; Fournier Gangrene; Humans; Hypoglycemic Agents; Kidney Fai | 2018 |